XML 38 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 2,511 $ 2,762
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 1,811 1,651
Deferred income taxes and investment tax credits (223) 234
Equity earnings (1,235) (1,086)
Share-based compensation expense 63 53
Fixed-price contracts and other derivatives 11 (580)
Bad debt expense 149 368
Other 7 6
Net change in working capital components 55 1,610
Distributions from investments 654 668
Changes in other noncurrent assets and liabilities, net (261) (557)
Net cash provided by operating activities 3,542 5,129
CASH FLOWS FROM INVESTING ACTIVITIES    
Expenditures for property, plant and equipment (5,765) (6,074)
Expenditures for investments (588) (281)
Purchases of nuclear decommissioning and other trust assets (658) (462)
Proceeds from sales of nuclear decommissioning and other trust assets 704 503
Other 11 10
Net cash used in investing activities (6,296) (6,304)
CASH FLOWS FROM FINANCING ACTIVITIES    
Common dividends paid (1,121) (1,109)
Preferred dividends paid (22) (22)
Issuances of common stock 26 0
Repurchases of common stock (41) (32)
Issuances of debt (maturities greater than 90 days) 6,437 6,911
Payments on debt (maturities greater than 90 days) and finance leases (2,216) (6,018)
(Decrease) increase in short-term debt, net (929) 629
Advances from unconsolidated affiliates 85 31
Proceeds from sales of noncontrolling interests, net 0 1,238
Distributions to noncontrolling interests (235) (289)
Contributions from noncontrolling interests 1,121 1,036
Settlement of cross-currency swaps 0 (99)
Other (39) (78)
Net cash provided by financing activities 3,066 2,198
Effect of exchange rate changes on cash, cash equivalents and restricted cash (11) 6
Increase in cash, cash equivalents and restricted cash 301 1,029
Cash, cash equivalents and restricted cash, January 1 389 462
Cash, cash equivalents and restricted cash, September 30 690 1,491
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Interest payments, net of amounts capitalized 814 836
Income tax payments, net of refunds 272 162
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES    
Accrued interest receivable added to note receivable 13 12
Repayments of advances from unconsolidated affiliate in lieu of distributions 62 36
Accrued capital expenditures 1,059 1,200
Increase in finance lease obligations for investment in PP&E 27 47
Decrease in ARO for investment in PP&E (9) (15)
Common dividends issued in stock 40 0
Contributions from NCI 0 200
Sale of NCI post-closing adjustment payable 0 11
Preferred stock    
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES    
Dividends declared but not paid 22 22
Common stock    
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES    
Dividends declared but not paid $ 392 $ 374